Amgen says its experimental drug helped patients lose 20% of weight, Wall Street is not impressed ...Middle East

Amgen (AMGN) reported today the highly anticipated results of a mid-stage trial of its experimental weight-loss drug and potential Ozempic competitor MariTide, however, Wall Street wasn’t very impressed.Read more...

Hence then, the article about amgen says its experimental drug helped patients lose 20 of weight wall street is not impressed was published today ( Tuesday 26/11/2024 - 09:00 PM ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Amgen says its experimental drug helped patients lose 20% of weight, Wall Street is not impressed )

Also on site :

• KELLAN A. WARREN, MELISSA L. WARREN, AND THE KELLAN CODY WARREN GS-TRUST TO AUCTION 10,000 SHARES OF COMMON STOCK OF KELLAN, INC., VIA PUBLIC SALE
• The High Cost of Buying Local in a Global Price War
• ICE detention staff reported death of restrained man as a suicide